Kappa Therapeutics
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2016 | 0 | 0 | 0 | — | — |
| 2017 | 28,163 | 32,492 | −4,329 | 7.1 | — |
| 2018 | 10 | 10 | 0 | 23138.4 | — |
| 2019 | 42,918 | 19,315 | 23,603 | 26.6 | — |
| 2020 | 2,012 | 252 | 1,760 | 2126.0 | — |
| 2021 | 11,801 | 9,596 | 2,205 | 58.6 | — |
| 2022 | 2 | 5,160 | −5,158 | 97.0 | — |
| 2023 | 8,539 | 31,968 | −23,429 | 6.9 | — |
In its most recent public year (2023), this organization spent $23,429 more than it brought in. Its reserves stood at about 6.9 months of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works